quinazolines has been researched along with rolipram in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (77.78) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, RL; Chapin, DS; Chen, JB; Helweg, D; Johnson, JL; Koe, BK; Lebel, LA; Lowe, JA; Moore, PF; Nielsen, JA | 1 |
| Howell, LL; Landrum, AM | 1 |
| Bateman-Fite, R; Brackeen, MF; Clark, RL; Connolly, KM; Menius, JA; Noel, LS; Sekut, L; Stimpson, SA; Yarnall, D | 1 |
| Forssmann, WG; Jonas, U; Meyer, M; Schulz-Knappe, P; Stief, CG; Taher, A; Truss, M | 1 |
| Byrd, LD; Howell, LL | 1 |
| Heaslip, R; Molnar-Kimber, K; Weichman, B; Yonno, L | 1 |
| Becker, AJ; Forssmann, WG; Jonas, U; Meyer, M; Schulz-Knappe, P; Stief, CG; Taher, A; Truss, M; Uckert, S | 1 |
| Beleta, J; Palacios, JM; Segarra, V | 1 |
| Dousa, TP; Grande, JP; Johnson, RJ; Shankland, SJ; Tsuboi, Y; Walker, HJ | 1 |
| Barnes, PJ; Giembycz, MA; Kelly, JJ | 1 |
| Forssmann, WG; Jonas, U; Meyer, M; Stief, CG; Taher, A | 1 |
| Dousa, TP; Grande, JP; Matousovic, K; Tsuboi, Y; Walker, H | 1 |
| Endo, T; Hirafuji, M; Kato, K; Minami, M; Ogawa, T; Satoh, Y; Suzuguchi, T | 1 |
| Horiuchi, M; Mita, S; Oki, K; Senda, T; Tsuji, F | 1 |
| Bischoff, E; Jonas, U; Kühn, R; Lietz, B; Schramm, M; Stief, CG; Truss, MC; Uckert, S | 1 |
| Dal Piaz, V; Giovannoni, MP | 1 |
| Kim, E; Kim, JH; Kim, SH; Nam, G; Rhee, CK; Shin, JH; Yoon, CM | 1 |
| Cheng, J; Grande, JP; Gray, CE; Thompson, MA; Walker, HJ; Warner, GM; Zhou, W | 1 |
2 review(s) available for quinazolines and rolipram
| Article | Year |
|---|---|
Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors.
Topics: Animals; Humans; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinazolines; Rolipram; Second Messenger Systems; Structure-Activity Relationship | 1995 |
Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Arthritis, Rheumatoid; Asthma; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Isoenzymes; Lung Diseases, Obstructive; Molecular Structure; Phosphodiesterase Inhibitors; Quinazolines; Rolipram; Theophylline; Xanthines | 2000 |
16 other study(ies) available for quinazolines and rolipram
| Article | Year |
|---|---|
Structure-activity relationship of quinazolinedione inhibitors of calcium-independent phosphodiesterase.
Topics: Animals; Brain; Chemical Phenomena; Chemistry; Male; Mice; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinazolines; Rats; Rolipram; Structure-Activity Relationship | 1991 |
Attenuation of hypoxia-induced increases in ventilation by adenosine antagonists in rhesus monkeys.
Topics: Adenosine; Animals; Hypoxia; Macaca mulatta; Male; Phosphodiesterase Inhibitors; Pyrrolidinones; Quinazolines; Respiration; Rolipram; Triazoles | 1995 |
Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Female; Galactosamine; Inflammation; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Phosphodiesterase Inhibitors; Purinones; Pyridazines; Pyrrolidinones; Quinazolines; Rats; Rats, Inbred Lew; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha | 1995 |
Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calmodulin; Chromatography, DEAE-Cellulose; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Humans; Hydrolysis; In Vitro Techniques; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; Papaverine; Phosphodiesterase Inhibitors; Purinones; Pyrrolidinones; Quinazolines; Rolipram; Ureter | 1994 |
Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.
Topics: Animals; Behavior, Animal; Caffeine; Drug Interactions; Drug Synergism; Male; Purinergic P1 Receptor Antagonists; Pyrrolidinones; Quinazolines; Receptors, Purinergic P1; Rolipram; Saimiri; Time Factors; Triazoles | 1993 |
Modulation of TNF alpha and IL-1 beta from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors.
Topics: Cell Survival; Cells, Cultured; Endotoxins; Humans; Interleukin-1; Isoenzymes; Milrinone; Monocytes; Phosphodiesterase Inhibitors; Purinones; Pyridones; Pyrrolidinones; Quinazolines; Rolipram; Tumor Necrosis Factor-alpha; Vinca Alkaloids | 1993 |
Phosphodiesterase isoenzymes in human ureteral smooth muscle: identification, characterization, and functional effects of various phosphodiesterase inhibitors in vitro.
Topics: Chromatography, Ion Exchange; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Humans; Hydrolysis; In Vitro Techniques; Isoenzymes; Muscle Contraction; Muscle, Smooth; Papaverine; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Quinazolines; Rolipram; Ureter | 1995 |
Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Actins; Animals; Blood Pressure; Calcium-Calmodulin-Dependent Protein Kinases; Glomerulonephritis, Membranoproliferative; Hydralazine; Isoenzymes; Kidney Function Tests; Kidney Glomerulus; Laminin; Male; Phosphodiesterase Inhibitors; Proteinuria; Pyrrolidinones; Quinazolines; Rats; Rats, Wistar; Rolipram; Superoxides | 1996 |
Phosphodiesterase 4 in macrophages: relationship between cAMP accumulation, suppression of cAMP hydrolysis and inhibition of [3H]R-(-)-rolipram binding by selective inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Binding Sites; Brain; Chromatography, Ion Exchange; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Guinea Pigs; Isoenzymes; Isoproterenol; Kinetics; Macrophages, Peritoneal; Male; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Quinazolines; Rats; Regression Analysis; Rolipram; Stereoisomerism; Thiazoles; Tritium | 1996 |
Cyclic nucleotide phosphodiesterase in human cavernous smooth muscle.
Topics: Animals; Cyclic AMP; Cyclic GMP; Humans; In Vitro Techniques; Isoenzymes; Male; Muscle, Smooth; Papaverine; Penile Erection; Penis; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrrolidinones; Quinazolines; Rolipram | 1997 |
Inhibitors of cyclic nucleotide phosphodiesterase isozymes block renal tubular cell proliferation induced by folic acid.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Division; Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Down-Regulation; Folic Acid; Isoenzymes; Kidney Tubules; Male; Phosphodiesterase Inhibitors; Proliferating Cell Nuclear Antigen; Pyrrolidinones; Quinazolines; Quinolones; Rats; Rats, Sprague-Dawley; Rolipram; Signal Transduction; Tetrazoles | 1997 |
[Signal transduction of serotonin release from enterochromaffin cells in mouse ileal crypts].
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Calcium; Clonidine; Enterochromaffin Cells; Ileum; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Norepinephrine; Phosphodiesterase Inhibitors; Prazosin; Pyrrolidinones; Quinazolines; Quinoxalines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Rolipram; Serotonin; Signal Transduction; Yohimbine | 1998 |
Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Calcium-Calmodulin-Dependent Protein Kinases; Cytokines; Dose-Response Relationship, Drug; Humans; Imidazoles; Interleukin-1; Phosphodiesterase Inhibitors; Pyridines; Pyrrolidinones; Quinazolines; Rolipram; Synovial Membrane | 1999 |
Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways.
Topics: Colforsin; Cyclic AMP; Cyclic GMP; Humans; In Vitro Techniques; Isoquinolines; Muscle, Smooth; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Platelet Aggregation Inhibitors; Potassium Chloride; Purinones; Quinazolines; Rolipram; Tetrahydroisoquinolines; Ureter; Vasodilator Agents | 2000 |
Syntheses and evaluation of pyrido[2,3-dlpyrimidine-2,4-diones as PDE 4 inhibitors.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Biological Assay; Cyclic Nucleotide Phosphodiesterases, Type 4; Humans; Molecular Structure; Phosphodiesterase Inhibitors; Pyrimidines; Quinazolines; Rats; Rolipram | 2001 |
Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cell Cycle Proteins; Cell Line; Colforsin; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclin D; Cyclin E; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Dogs; Epithelial Cells; Gene Expression Regulation, Enzymologic; Kidney; Mitosis; Phosphodiesterase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Quinazolines; Rolipram | 2006 |